Diahema - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 121,367 | 209,081 | 475,594 | 601,399 | 702,669 | 751,311 | 845,840 | 890,173 |
| Profit before tax | -44,266 | -37,200 | 49,241 | 97,441 | 121,936 | 88,014 | 101,742 | 121,473 |
| Net profit | -44,266 | -37,200 | 49,241 | 97,099 | 121,731 | 87,779 | 101,505 | 110,541 |
| Equity | -43,006 | -80,206 | -30,965 | 65,783 | 187,514 | 276,474 | 377,979 | 468,520 |
| Liabilities | 484,809 | 534,145 | 524,008 | 468,720 | 286,761 | 215,083 | 110,675 | 57,053 |
| Non-current assets | 411,334 | 401,991 | 356,583 | 318,334 | 276,254 | 292,333 | 261,130 | 227,305 |
| Current assets | 30,297 | 52,001 | 136,229 | 215,934 | 197,814 | 198,783 | 226,878 | 297,664 |
| Total assets | 441,631 | 453,992 | 492,812 | 534,268 | 474,068 | 491,116 | 488,008 | 524,969 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 69,415 | 80,269 | 91,830 |
| Social insurance contributions | - | - | - | - | - | 87,594 | 102,455 | 111,959 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +40.5% | +72.3% | +127.5% | +26.5% | +16.8% | +6.9% | +12.6% | +5.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -10.0% | -8.2% | 10.0% | 18.2% | 25.7% | 17.9% | 20.8% | 21.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 147.6% | 64.9% | 31.7% | 26.9% | 23.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -36.5% | -17.8% | 10.4% | 16.1% | 17.3% | 11.7% | 12.0% | 12.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -36.5% | -17.8% | 10.4% | 16.2% | 17.4% | 11.7% | 12.0% | 13.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 7.1 | 1.5 | 0.8 | 0.3 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,185 | 13,136 | 23,780 | 28,081 | 29,483 | 30,356 | 32,325 | 35,138 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Diahema - Social security debts
The company had no debts to Sodra
Diahema - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Diahema, UAB, company code 304147933, is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €890.2K and net profit of €110.5K, corresponding to a profit margin of 12.4%. Revenue increased by 5.2% year on year and by 18.5% over two years, showing a steady upward trend. Net profit also improved from €87.8K in 2023 to €101.5K in 2024 and €110.5K in 2025. The balance sheet remained solid, with total assets of €525.0K, equity of €468.5K and liabilities of €57.1K at the end of 2025. The equity ratio stood at 89.2% and debt to equity at 0.12, indicating a strong capital structure. Asset turnover was 1.70x, while revenue per employee reached €35.6K and profit per employee €4.4K, suggesting stable operating efficiency.